Thunderclap Research
Subscriber Login
Search
  • About
    • About Us
    • Tim Melvin
    • Garrett Baldwin
  • Commentary
  • SPAC Investing
  • Education Center
  • Publications
    • Tim Melvin’s Takeover Targets
  • Subscriber Login
Sign Up

Garrett Baldwin

Commentary

Notes from the Florida Republic: The Issue (No. 4) with Elon Musk and Our Citizenship Test

Commentary |

Garrett Baldwin |

March 1, 2021

People ask me (Garrett Baldwin) all the time why I don’t invest in Tesla for the long term.  A few reasons…  They’re pretty obvious, even if you’ve taken down a bottle of McCallan on a Tuesday morning.  It’s trading as…

Learn more

Commentary

Postcards from the Florida Republic: Part III

Commentary |

Garrett Baldwin |

February 19, 2021

As I’ve said before, the Florida Republic is a basic effort to stabilize after Washington forgets we exist (and vote).

Learn more

Market Updates

Dow Futures Rallies Higher After Pfizer Announces Final Results of Drug Trial

Market Updates |

Garrett Baldwin |

November 18, 2020

Good morning. Dow Jones futures today were pushing higher this morning after Pfizer reported 95% efficacy on its latest COVID-19 vaccine. That figure suggests that the new vaccine is more successful than previous data noted. The Dow Futures added another…

Learn more

Market Updates

The Great Rotation Continues on Vaccine News; Elon Musk Becomes World’s No. 3 Richest Person

Market Updates |

Garrett Baldwin |

November 17, 2020

The Dow Jones slumped more than 160 points in premarket hours as investors continued to rotate from growth stocks into more cyclical stocks. Recent announcements by Pfizer (PFE) and Moderna (MRNA) on their new vaccines has given investors optimism that…

Learn more

Market Updates

Stock Futures Flat as Investors Weigh Vaccine Timing, Risks of New Shutdowns

Market Updates |

Garrett Baldwin |

November 13, 2020

The Dow Jones today was off 64 points in pre-market hours as investors digest the latest rounds of earnings reports and COVID updates. Let’s take a look at the numbers from Thursday before we get into the headlines driving the…

Learn more

Market Updates

Dow Continues Breakout Rally After Pfizer Vaccine News

Market Updates |

Garrett Baldwin |

November 10, 2020

The Dow Jones today is up another 200 points in premarket hours. Investors continue to cheer a day after Pfizer (PFE) announced that it has developed a COVID vaccine with 90% efficacy. Yesterday’s announcement sent the Dow up more than…

Learn more

Market Updates

Market Blowout on Vaccine Progress, News of Biden Victory

Market Updates |

Garrett Baldwin |

November 9, 2020

The S&P futures surged today on two catalysts Monday. First, global markets cheered the prospect of Joe Biden winning the 2020 election and presiding over a divided government. The general attitude is that Biden will not be able to introduce…

Learn more
123...>

Subscribe to Thunderclap Research for FREE

Receive wealth-building advice delivered straight to your inbox.

Premium Services

Tim Melvin’s Takeover Targets >>

Thunderclap Research

© 2022 Thunderclap Research. All rights reserved

Publications

  • Tim Melvin’s Takeover Targets

Our Team

  • Tim Melvin
  • Garrett Baldwin

About Us

  • Contact
  • About Us
  • FAQ
  • Privacy Policy
  • Terms of Use
  • We’re Hiring

Subscribe

Sign Up